ישראל - עברית - Ministry of Health

sanofi israel ltd - cemiplimab - תרכיז להכנת תמיסה לאינפוזיה - cemiplimab 50 mg / 1 ml - cemiplimab

ישראל - עברית - Ministry of Health

merck serono ltd - cetuximab - תמיסה לאינפוזיה - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, kras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

ישראל - עברית - Ministry of Health

truemed ltd, israel - emapalumab - תרכיז להכנת תמיסה לאינפוזיה - emapalumab 5 mg / 1 ml - emapalumab

ישראל - עברית - Ministry of Health

sanofi israel ltd - sutimlimab - תמיסה לאינפוזיה - sutimlimab 50 mg / 1 ml - sutimlimab

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - nivolumab; relatlimab - תרכיז להכנת תמיסה לאינפוזיה - relatlimab 4 mg/ml; nivolumab 12 mg/ml - nivolumab

ישראל - עברית - Ministry of Health

amgen europe b.v. - panitumumab - תרכיז להכנת תמיסה לאינפוזיה - panitumumab 20 mg / 1 ml - panitumumab - in combination with chemotherapy for the treatment of unresectable, advanced or recurrent colorectal cancer (mcrc) with wild-type kras.monotherapy for the treatment of patients with metastatic colorectal carcinoma with wild-type kras after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.

ישראל - עברית - Ministry of Health

medison pharma ltd - encorafenib - קפסולות ג'לטין קשיחות - encorafenib 75 mg - encorafenib